| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4K | — | — |
| Cost of Revenue | $2K | — | — |
| Gross Profit | $2K | — | — |
| R&D Expense | $400K | -70.5% | -0.3% |
| SG&A Expense | $1.4M | -21.9% | -45.1% |
| Operating Income | -$1.8M | +43.0% | +39.1% |
| Pre-tax Income | -$2.1M | -123.0% |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $115K | -90.2% | — |
| Accounts Receivable | $5K | +411.6% | +411.6% |
| Inventory | $24K | +0.0% | +0.0% |
| Current Assets | $1.2M | -53.2% | -24.8% |
| Total Assets | $5.3M | -19.8% | -18.4% |
| Current Liabilities | $19.4M |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.3M | -39.0% | — |
| Capital Expenditures | $118K | — | — |
| Investing Cash Flow | -$181K | -352.0% | — |
| Financing Cash Flow | $198K | -0.2% | — |
| Free Cash Flow | -$3.4M | — | — |
| -109.6% |
| Net Income | -$2.1M | -123.0% | -109.6% |
| EPS (Basic) | -$0.70 | -122.9% | -380.0% |
| EPS (Diluted) | -$0.70 | -123.0% | -404.3% |
| — |
| — |
| Total Liabilities | $19.4M | +3.2% | -21.3% |
| Stockholders' Equity | -$14.1M | -15.7% | +22.4% |